Source: Mediators of Inflammation. Conference titles: World Congress on Inflamation. Unidade: ICB
Assunto: FARMACOLOGIA
ABNT
CRUZ, J. W. M. C. e HOHMAN, T. e FORTES, Zuleica Bruno. Polyol Pathway products are involved in the defective endothelial-leucocyte interaction in diabetes mellitus (DM). Mediators of Inflammation. Paris: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 13 nov. 2024. , 1999APA
Cruz, J. W. M. C., Hohman, T., & Fortes, Z. B. (1999). Polyol Pathway products are involved in the defective endothelial-leucocyte interaction in diabetes mellitus (DM). Mediators of Inflammation. Paris: Instituto de Ciências Biomédicas, Universidade de São Paulo.NLM
Cruz JWMC, Hohman T, Fortes ZB. Polyol Pathway products are involved in the defective endothelial-leucocyte interaction in diabetes mellitus (DM). Mediators of Inflammation. 1999 ; 8( 1):[citado 2024 nov. 13 ]Vancouver
Cruz JWMC, Hohman T, Fortes ZB. Polyol Pathway products are involved in the defective endothelial-leucocyte interaction in diabetes mellitus (DM). Mediators of Inflammation. 1999 ; 8( 1):[citado 2024 nov. 13 ]